Was Just Added into NASDAQ Biotechnology Index --- ASPV

ASPV (Aspreva Pharmaceuticals Corporation)

ASPV engages in the identification, development, and commercialization of new indications for approved drugs and late stage drug candidates for patients living with less common diseases.

ASPV has an outstanding business model in the pharmaceutical industry. It is good for both short and long term investors.

Its closing price, as of 5/25/06, is $29.15.

My suggestion: Buy (7.5)